Chronic Total Occlusion Market to Perceive Substantial Growth at 8.1% of CAGR by 2025 – SPECTRANETICS, C. R. Bard, Boston Scientific Corporation, Medtronic, Terumo Corporation, Cordis, Abbott
Chronic total occlusion (CTO) occurs when a coronary artery is completely blocked with plaque for more than three months. CTO obstructs the flow of blood to the heart and can have severe effects on the health. When one or more of coronary arteries are completely blocked, the patients are at higher risk for a heart attack. A percutaneous coronary interventional (PCI) procedure is the appropriate treatment option for patients that have poor blood flow through one or more coronary arteries.
Hospitals Segment is expected to grow the Market for Chronic Total
Occlusion over the Forecast Period for End User Segment.
According to a new market research study titled ‘Chronic total occlusion Market
to 2025 - Global Analysis and Forecasts by Equipment and End User. The global
chronic total occlusion market is expected to reach US$ 516.1 Mn in 2025 from
US$ 280.7 in 2017. The market is estimated to grow with a CAGR of 8.1% from
2018-2025. The report highlights the trends prevalent in the global chronic
total occlusion market and the factors driving the market along with those that
act as deterrents to its growth.
Get Sample Copy at https://www.theinsightpartners.com/sample/TIPMD00002711
The report segments the global
chronic total occlusion market as follows:
Global chronic total occlusion Market - By Equipment
Micro Catheters
Guide Wires
Crossing Devices
Re-Entry Devices
Global Chronic total occlusion Market - By End User
Hospitals
Ambulatory Care Centers
Others
Global Chronic total occlusion Market - By Geography
North America
U.S.
Canada
Mexico
Europe
U.K.
Germany
France
Asia Pacific (APAC)
Japan
China
India
Middle East & Africa (MEA)
South Africa
UAE
Saudi Arabia
South & Central America (SCAM)
Brazil
Browse Complete Report at https://www.theinsightpartners.com/reports/chronic-total-occlusion-market
Global chronic total occlusion market, based on end user was segmented
hospitals, ambulatory care centers and others. In 2017, hospitals segment held
the largest share of the market, by end user. CTOs are blockages that have
typically been present for above than three months. These blockages are a
result of severe build-up of fatty deposits or plaque within the arteries
(atherosclerosis) and are one of the complications from coronary artery disease
(CAD). Hospitals dominate the end user segment as it is the primary health
systems in most of the countries. Hence the number of CTO procedures in
hospitals is more than any other healthcare facility. Also, increasing adoption
of new technology devices in the hospitals and rising hospital research drives
the market growth. Thus, hospitals is expected to dominate the end-user segment
during the forecast period.
The market for chronic total occlusion is expected to grow as increasing demand
for minimally invasive surgical procedures, rising prevalence of artery
diseases, technological advancements, and rising geriatric population are
expected to fuel the market growth during the forecast period. In addition,
increasing medical tourism in emerging nations are likely to have a positive
impact on the growth of the global chronic total occlusion market in the coming
years.
The major players operating in the chronic total occlusion market are ASAHI
INTECC CO., LTD, SoundBite Medical Solutions, Integer Holdings Corporation,
Baylis Medical Company, Inc, SPECTRANETICS, C. R. Bard, Inc., Boston Scientific
Corporation, Medtronic, Terumo Corporation, Cordis, and Abbott. For instance,
in August 2017, Koninklijke Philips N.V. completed the acquisition of The
Spectranetics Corporation in order to accelerate its strategic expansion into
cardiovascular devices.
Inquire more at https://www.theinsightpartners.com/inquiry/TIPMD00002711/
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: [email protected]